A 'Fillip' For UK Biotech
Roche Buying Privately Held Piramed for $160M Up Front
Less than five years after its founding, privately held Piramed Ltd. agreed to be acquired by Roche Holdings Ltd. for $160 million up front in one of the few recent deals to stand out in the slumping UK biotech sector. (BioWorld Today)